Acarix AB Stock Nasdaq Stockholm
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- SEK | - |
Sales 2023 | 6.24M 568K | Sales 2024 * | 86.9M 7.91M | Capitalization | 193M 17.6M |
---|---|---|---|---|---|
Net income 2023 | -77M -7.01M | Net income 2024 * | -24M -2.19M | EV / Sales 2023 | 22.4 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | 4 0.36 | EV / Sales 2024 * | 2.22 x |
P/E ratio 2023 |
-1.19
x | P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 88.07% |
Latest transcript on Acarix AB
Managers | Title | Age | Since |
---|---|---|---|
Founder | 60 | 06-12-31 | |
Director of Finance/CFO | 60 | 15-12-31 | |
Jennifer Matson
CTO | Chief Tech/Sci/R&D Officer | 47 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 51 | 21-05-10 | |
Ulf Rosén
BRD | Director/Board Member | 64 | 13-12-31 |
Director/Board Member | 70 | 21-05-10 |
1st Jan change | Capi. | |
---|---|---|
-48.09% | 2.59B | |
+4.82% | 1.61B | |
-12.79% | 1.43B | |
+22.29% | 1.22B | |
-14.90% | 979M | |
-23.61% | 880M | |
-9.43% | 718M | |
-17.46% | 687M | |
+3.77% | 474M |